Suppr超能文献

癫痫中电压门控钾通道和钙通道的抗体

Antibodies to voltage-gated potassium and calcium channels in epilepsy.

作者信息

Majoie H J Marian, de Baets Mark, Renier Willy, Lang Bethan, Vincent Angela

机构信息

Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands.

出版信息

Epilepsy Res. 2006 Oct;71(2-3):135-41. doi: 10.1016/j.eplepsyres.2006.06.003. Epub 2006 Jul 25.

Abstract

OBJECTIVE

To determine the prevalence of antibodies to ion channels in patients with long standing epilepsy.

BACKGROUND

Although the CNS is thought to be protected from circulating antibodies by the blood brain barrier, glutamate receptor antibodies have been reported in Rasmussen's encephalitis, glutamic acid decarboxylase (GAD) antibodies have been found in a few patients with epilepsy, and antibodies to voltage-gated potassium channels (VGKC) have been found in a non-paraneoplastic form of limbic encephalitis (with amnesia and seizures) that responds to immunosuppressive therapy.

METHODS

We retrospectively screened sera from female epilepsy patients (n=106) for autoantibodies to VGKC (Kv 1.1, 1.2 or 1.6), voltage-gated calcium channels (VGCC) (P/Q-type), and GAD. All positive results, based on the values of control data [McKnight, K., Jiang, Y., et al. (2005). Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65, 1730-1735], were retested at lower serum concentrations, and results compared with previously published control data. Demographics, medical history, and epilepsy related information was gathered.

RESULTS

The studied group consisted predominantly of patients with long standing drug resistant epilepsy. VGKC antibodies were raised (>100 pM) in six patients. VGCC antibodies (>45 pM) were slightly raised in only one patient. GAD antibodies were <3 U/ml in all patients. The clinical features of the patients with VGKC antibodies differed from previously described patients with limbic encephalitis-like syndrome, and were not different with respect to seizure type, age at first seizure, duration of epilepsy, or use of anti-epileptic drugs from the VGKC antibody negative patients.

CONCLUSION

The results demonstrate that antibodies to VGKC are present in 6% of patients with typical long-standing epilepsy, but whether these antibodies are pathogenic or secondary to the primary disease process needs to be determined.

摘要

目的

确定长期癫痫患者中离子通道抗体的患病率。

背景

尽管人们认为中枢神经系统受到血脑屏障的保护,免受循环抗体的影响,但在拉斯穆森脑炎中已报告有谷氨酸受体抗体,在少数癫痫患者中发现了谷氨酸脱羧酶(GAD)抗体,并且在一种对免疫抑制治疗有反应的非副肿瘤性边缘性脑炎(伴有失忆和癫痫发作)中发现了电压门控钾通道(VGKC)抗体。

方法

我们回顾性筛查了106例女性癫痫患者的血清,以检测针对VGKC(Kv 1.1、1.2或1.6)、电压门控钙通道(VGCC)(P/Q型)和GAD的自身抗体。根据对照数据[麦克奈特,K.,江,Y.等(2005年)。癫痫和癫痫相关疾病中的血清抗体。《神经病学》65,1730 - 1735]的数值,所有阳性结果均在较低血清浓度下重新检测,并将结果与先前发表的对照数据进行比较。收集了人口统计学、病史和癫痫相关信息。

结果

研究组主要由长期药物难治性癫痫患者组成。6例患者的VGKC抗体升高(>100 pM)。仅1例患者的VGCC抗体(>45 pM)略有升高。所有患者的GAD抗体均<3 U/ml。VGKC抗体阳性患者的临床特征与先前描述的边缘性脑炎样综合征患者不同,在癫痫发作类型、首次发作年龄、癫痫病程或抗癫痫药物使用方面与VGKC抗体阴性患者无差异。

结论

结果表明,典型长期癫痫患者中有6%存在VGKC抗体,但这些抗体是致病的还是继发于原发性疾病过程尚需确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验